初诊IgA肾病患者的肠道菌群及其与疾病进展因素的相关分析

Changes of gut microflora in newly diagnosed IgA nephropathy patients and its correlation with clinical risk factors

目的:观察慢性肾脏病(chronic kidney disease,CKD)1~2期的初诊IgA肾病患者肠道微生物群的特征,进一步探索IgA肾病疾病进展因素与肠道微生物之间的关系。方法:收集19例CKD 1~2期的初诊IgA肾病患者和15例年龄、性别相匹配的健康对照组的新鲜粪便样本,提取粪便细菌DNA,针对V3-V4区域进行16S核糖体RNA(16S ribosomal RNA,16S rRNA)高通量测序分析肠道菌群的组成,应用Illumina Miseq平台对粪便菌群测序结果进行分析。收集初诊IgA肾病患者的疾病进展因素,研究肠道菌群与IgA肾病疾病进展因素之间的相关性。结果:(1)与健康对照组相比,在门水平上,拟杆菌门(Bacteroidetes)的丰度显著降低(P=0.046),放线菌门(Actinobacteria)的丰度显著升高(P=0.001)。在属水平上,埃希菌-志贺菌属(Escherichia-Shigella)、双歧杆菌属(Bifidobacterium)、Dorea等菌属的丰度显著升高(P<0.05),毛螺菌属(Lachnospira)、粪球菌属_2(Coprococcus_2)、萨特氏菌属(Sutterella)等菌属的丰度显著降低(P<0.05)。(2)初诊IgA肾病患者与健康对照组之间肠道菌群的丰度比较差异无统计学意义(P>0.05),但两组肠道菌群的组成存在差异。LEfSe分析结果显示,初诊IgA肾病患者和健康对照组比较有16个差异菌,其中,初诊IgA肾病患者肠杆菌目(Enterobacteriales)、放线菌门、埃希菌-志贺菌属等的丰度升高,健康对照组拟杆菌门、毛螺菌属的丰度升高。(3)冗余分析(redundancy analysis,RDA)的结果显示,初诊IgA肾病患者粪便中双歧杆菌属与血清IgA水平、24 h尿蛋白定量和合并高血压呈正相关,Lachnoclostridium菌属与合并高血压呈正相关,埃希菌-志贺菌属与尿红细胞数量呈正相关,双歧杆菌属与毛细血管内增殖呈正相关,粪杆菌属与细胞/纤维细胞性新月体呈正相关,瘤胃球菌属_2(Ruminococcus_2)与系膜细胞增殖、肾小球节段硬化、肾小管萎缩/间质纤维化呈正相关。结论:初诊CKD 1~2期IgA肾病患者的肠道菌群与健康对照相比存在差异,肠道的某些菌属与IgA肾病疾病进展因素呈相关性,需要进一步的研究来了解这些菌属在IgA肾病中的潜在作用。

Objective:To investigate the gut microbiota in newly diagnosed IgA nephropathy patients with chronic kidney disease(CKD)stages 1-2 and the association between the gut microbiota and the clinical risk factors of IgA nephropathy.Methods:Fresh fecal samples were collected from nineteen newly diagnosed IgA nephropathy patients with CKD stages 1-2 and fifteen age-and sex-matched healthy controls.Fecal bacterial DNA was extracted and microbiota composition were characterized using 16S ribosomal RNA(16S rRNA)high-throughput sequencing for the V3-V4 region.The Illumina Miseq platform was used to analyze the results of 16S rRNA high-throughput sequencing of fecal flora.At the same time,the clinical risk factors of IgA nephropathy patients were collected to investigate the association between the gut microbiota and the clinical risk factors.Results:(1)At the phylum level,the abundance of Bacteroidetes was significantly reduced(P=0.046),and the abundance of Actinobacteria was significantly increased(P=0.001).At the genus level,the abundance of Escherichia-Shigella,Bifidobacte-rium,Dorea and others were significantly increased(P<0.05).The abundance of Lachnospira,Coprococcus_2 and Sutterella was significantly reduced(P<0.05).(2)There was no significant difference in the abundance of gut microbiota between the newly diagnosed IgA nephropathy patients and the healthy control group(P>0.05),but there were differences in the structure of the gut microbiota between the two groups.The results of LEfSe analysis showed that there were 16 differential bacteria in the newly diagnosed IgA nephropathy patients and healthy controls.Among them,the abundance of the newly diagnosed IgA nephropathy patients was increased in Enterobacteriales,Actinobacteria,Escherichia-Shigella,etc.The healthy control group was increased in Bacteroidetes and Lachnospira.(3)The result of redundancy analysis(RDA)showed that Bifidobacterium was positively correlated with serum IgA levels,24-hour urinary protein levels and the presence of hypertension.Lachnoclostridium was positively correlated with the presence of hypertension.Escherichia-Shigella was positively correlated with urine red blood cells account.Bifidobacterium was positively correlated with the proliferation of capillaries.Faecalibacterium was positively correlated with cell/fibrocytic crescents.Ruminococcus_2 was positively correlated with mesangial cell proliferation,glomerular segmental sclerosis and renal tubular atrophy/interstitial fibrosis.Conclusion:The gut microbiota in the newly diagnosed IgA nephropathy patients with CKD stages 1-2 is different from that of the healthy controls.Most importantly,some gut bacteria are related to the clinical risk factors of IgA nephropathy.Further research is needed to understand the potential role of these bacteria in IgA nephropathy.